Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]

Peer Review reports

Original Submission
23 Feb 2006	Submitted	Original manuscript
1 Jun 2006	Reviewed	Reviewer Report - Nehme Gabriel
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
8 Jun 2006	Editorially accepted
8 Jun 2006	Article published	10.1186/1475-2891-5-16

Back to article page